IWC
INDP icon

Integrated Wealth Concepts’s Indaptus Therapeutics INDP Stock Holding History

Integrated Wealth Concepts’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-185
Closed -$104K – 637
2020
Q3 		$104K Hold
185
– – 0.01% 554
2020
Q2 		$117K Buy
+185
New +$114K 0.01% 502

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's INDP Position: Q4 2020 in Review

Integrated Wealth Concepts sold out of Indaptus Therapeutics (INDP) in Q4 2020, closing a stake of 185 shares — an estimated $104K sold.

Integrated Wealth Concepts first reported a position in INDP in Q2 2020 and held it in 2 quarters. The position peaked at $117K in Q2 2020. 18 funds tracked by Wall St. Rank hold INDP as of Q4 2020.

  • Integrated Wealth Concepts reported no remaining Indaptus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Integrated Wealth Concepts sold 185 Indaptus Therapeutics shares in Q4 2020, an estimated $104K.
  • Integrated Wealth Concepts first reported a position in Indaptus Therapeutics in Q2 2020 and held it in 2 quarters.
  • Integrated Wealth Concepts's Indaptus Therapeutics position peaked at $117K in Q2 2020.
  • 18 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q4 2020.

Based on Integrated Wealth Concepts's 13F filing for Q4 2020, filed 12 Feb 2021.